Quantitative Diffusion and Fat Imaging of the Spine
1 other identifier
observational
21
1 country
1
Brief Summary
Primary Objective: The purpose of this study is to determine whether or not combined quantitative diffusion and fat MR imaging techniques can differentiate between benign and malignant vertebral fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2004
CompletedFirst Submitted
Initial submission to the registry
July 6, 2007
CompletedFirst Posted
Study publicly available on registry
July 10, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedAugust 1, 2012
July 1, 2012
4.9 years
July 6, 2007
July 31, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRIs of diffusion (the random motion of molecules) and fat
One extra 10 minute MRI sequence during scheduled spine exam.
Study Arms (1)
Spinal MRI
Interventions
One MRI sequence done to look for relative fat, and a second extra MRI sequence done to look for the diffusion.
Eligibility Criteria
Study participants with osteoporosis that have already been scheduled for MRI exams of the spine.
You may qualify if:
- \. Patients with suspected vertebral compression fractures scheduled a standard of care MRI of the spine.
You may not qualify if:
- Patients who are contraindicated for MRI (such as due to metal implants, cardiac pacemaker).
- Patients who are unable to give informed consent
- Patients who are younger than 18 years of age since the disease (osteoporosis) is not present in children.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.T.M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jingfei Ma, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2007
First Posted
July 10, 2007
Study Start
August 1, 2004
Primary Completion
July 1, 2009
Study Completion
July 1, 2009
Last Updated
August 1, 2012
Record last verified: 2012-07